1. bookVolumen 68 (2018): Edición 1 (March 2018)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Efficacy of nucleoside analogues for hepatitis B virus-related liver failure: A network meta-analysis

Publicado en línea: 16 Feb 2018
Volumen & Edición: Volumen 68 (2018) - Edición 1 (March 2018)
Páginas: 19 - 30
Aceptado: 04 Dec 2017
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. Y. Zhijian, L. Hui, Y. Weiming, L. Zhanzhou, C. Zhong, Z. Jinxin, W. Hongyan, D. Xiangbin, Y. Weizhi, L. Duoyun, L. Xiaojun and D. Qiwen, Role of the aspartate transaminase and platelet ratio index in assessing hepatic fibrosis and liver inflammation in adolescent patients with HBeAg-positive chronic hepatitis B, Gastroenterol. Res. Pract. 2015 (2015) Article ID 906026 (6 pages); https://doi.org/10.1155/2015/90602610.1155/2015/906026450682426236336Search in Google Scholar

2. Q. Zhou and H. Tang, The progress of antiviral therapy in patients with HBV-related liver failure, Hepatogastroenterology 60 (2013) 1877-1880.Search in Google Scholar

3. S. Locarnini, Molecular virology of hepatitis B virus, Semin. Liver Dis. 24 (Suppl 1) (2004) 3-10.10.1055/s-2004-82867215192795Search in Google Scholar

4. Y. F. Liaw, Hepatitis B virus replication and liver disease progression: the impact of antiviral therapy, Antivir. Ther. 11 (2006) 669-679.10.1177/135965350601100614Search in Google Scholar

5. Y. N. Ye and Z. L. Gao, Three attacks in the development of HBV-related liver failure, Infect. Dis. Inf. 22 (2009) 276-279; https://doi.org/10.3969/j.issn.1007-8134.2009.05.006Search in Google Scholar

6. S. Uemoto, Y. Inomata, T. H. Egawa, S. Fujita, T. Kiuchi, M. Hayashi, M. Yasutomi, H. Yamabe and K. Tanaka, Living donor liver transplantation for fulminant hepatic failure, Transplant. Proc. 42 (2010) 990-993; https://doi.org/10.18926/AMO/55435Search in Google Scholar

7. J. Gu, X. Shi, H. Ren, Q. Xu and J. Wang, Systematic review: extracorporeal bio-artificial liversupport system for liver failure, Hepatol. Int. 6 (2012) 670-683; https://doi.org/10.1007/s12072-012-9352-910.1007/s12072-012-9352-926201519Search in Google Scholar

8. M. K. Jain, L. Comanor, C. White, P. Kipnis, C. Elkin, K. Leung, A. Ocampo, N. Attar, P. Keiser and W. M. Lee, Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response, J. Viral Hepatitis 14 (2007) 176-182; https://doi.org/10.1111/j.1365-2893.2006.00797.x10.1111/j.1365-2893.2006.00797.x17305883Search in Google Scholar

9. Y. W. Kim, J. H. Kwon, E. Chung, S. W. Lee, J.-y. Lee, J. W. Jang, K. W. Chung and S. W. Nam, Short term virologic efficacies of telbivudine versus entecavir against hepatitis B-related hepatocellular carcinoma, Gastroenterol. Res. Pract. 2015 (2015) Article ID 181065 (7 pages); https://doi.org/10.1155/2015/18106510.1155/2015/181065438797325878659Search in Google Scholar

10. J. F. Zhang, Y. Guo, C. X. Chen, H. Y. Song, J. Dong, X. Chen, Z. L. Chen and B. Liu, A study on the treatment effect of telbivudine on hepatitis B patients with acute on chronic liver failure, Mil. Med. J. Southeast China (2016); https://doi.org/10.3760/cma.j.issn.1007-3418.2015.01.006Search in Google Scholar

11. S. S. Ma, Effect of enticavir on survival of patients with HBV-related liver failure: A meta-analysis, Shi Jie Hua Ren Xiao Hua Za Zhi (World Chin. J. Digestol.) 21 (2013) 2594-2600.Search in Google Scholar

12. B. Hutton, G. Salanti, D. M. Caldwell, A. Chaimani, C. H. Schmid, C. Cameron, J. P. A. Ioannidis, S. Straus, K. Thorlund, J. P. Jansen, C. Mulrow, F. Catalá-López, P. C. Gøtzsche, K. Dickersin, I. Boutron, D. G. Altman and D. Moher, The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: Checklist and explanations, Ann. Intern. Med. 162 (2015) 777-784; https://doi.org/10.7326/m14-238510.7326/M14-238526030634Search in Google Scholar

13. C. P. Robert and G. Casella, Monte Carlo Statistical Methods, 2nd ed., Springer, New York, 2004.10.1007/978-1-4757-4145-2Search in Google Scholar

14. S. P. Brooks and A. Gelman, General methods for monitoring convergence of iterative simulations, J. Comput. Graph. Stat. 7 (1998) 434-455.Search in Google Scholar

15. T. Kanda, M. Shinozaki, H. Kamezaki, S. Wu, S. Nakamoto, M. Arai, K. Fujiwara, N. Goto, F. Imazeki and O. Yokosuka, Efficacy of lamivudine or entecavir on acute exacerbation of chronic hepatitis B, Int. J. Med. Sci. 9 (2012) 27-32.10.7150/ijms.9.27322208722211086Search in Google Scholar

16. B. Lin, C. Q. Pan, D. Xie, J. Xie, S. Xie, X. Zhang, B. Wu, C. Lin and Z. Gao, Entecavir improves the outcome of acute-on-chronic liver failure due to the acute exacerbation of chronic hepatitis B, Hepatol. Int. 7 (2013) 460-467; https://doi.org/10.1007/s12072-012-9415-y10.1007/s12072-012-9415-y26201778Search in Google Scholar

17. L. J. Sun, J. W. Yu, Y. H. Zhao, P. Kang and S. C. Li, Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure, J. Gastroenterol. Hepatol. 25 (2010) 583-590; https://doi.org/10.1111/j.1440-1746.2009.06089.x10.1111/j.1440-1746.2009.06089.xSearch in Google Scholar

18. L. Wang, H. Chen, C. Fan and Z. Gong, Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection, J. Med. Virol. 85 (2013) 1907-1912; https://doi.org/10.1002/jmv.2368910.1002/jmv.23689Search in Google Scholar

19. Y. Xianghui, X. Lang, Z. Yan, Z. Li, S. Xiaofeng and R. Hong, Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: Using virologic response at week 4, Eur. J. Intern. Med. 25 ( 2014) 8 60-864; https://doi.org/10.1016/j.ejim.2014.10.00710.1016/j.ejim.2014.10.007Search in Google Scholar

20. T. Chen, Y. He, X. Liu, Z. Yan, K. Wang, H. Liu, S. Zhang and Y. Zhao, Nucleoside analogues improve the short-term and long-term prognosis of patients with hepatitis B virus-related acute-onchronic liver failure, Clin. Exp. Med. 12 (2012) 159-164; https://doi.org/10.1007/s10238-011-0160-710.1007/s10238-011-0160-7Search in Google Scholar

21. Y. L. Cui, Y. Fang, Y. B. Wang, X. Q. Song, L. Li, X. Z. Lei, M. H. Zheng, T. Hong and F. Ping, Nucleoside analogue can improve the long-term prognosis of patients with hepatitis B virus infection- associated acute or chronic liver failure, Dig. Dis. Sci. 55 ( 2010) 2 373-2380; https://doi.org/10.1007/s10620-010-1257-710.1007/s10620-010-1257-7Search in Google Scholar

22. H. Garg, S. K. Sarin, M. Kumar, V. Garg, B. C. Sharma and A. Kumar, Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure, Hepatology 53 (2011) 774-780; https://doi.org/10.1002/hep.2410910.1002/hep.24109Search in Google Scholar

23. K. Ma, W. Guo, M. Han, G. Chen, T. Chen, Z. Wu, D. Yang, J. Huang, Y. Huang, X. Zhao, J. Song, J. Qi and Q. Ning, Entecavir treatment prevents disease progression in HBV related acute-onchronic liver failure: Establishment of a novel logistical regression model, The International Liver Congress™ 201 - 46th annual meeting of the European Association for the Study of the Liver, Berlin, March 30 to April 3, 2011, Poster 742, J. Hepatol. 54 (Suppl. 1) (2011) S298; https://doi.org/10.1016/S0168-8278(11)60744-710.1016/S0168-8278(11)60744-7Search in Google Scholar

24. J. Lai, Y. Yan, L. Mai, Y. B. Zheng, W. Q. Gan and W. M. Ke, Short-term entecavir versus lamivudine therapy for HBeAg-negative patients with acute-on-chronic hepatitis B liver failure, Hepatob. Pancreat. Dis. Int. 12 (2013) 154-159.10.1016/S1499-3872(13)60025-9Search in Google Scholar

25. Y. Zhang, X. Y. Hu, S. Zhong, F. Yang, T. Y. Zhou, G. Chen, Y. Y. Wang and J. X. Luo, Entecavir vs lamivudine therapy for naïve patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure, World J. Gastroenterol. 20 (2014) 4745-4752; https://doi.org/10.3748/wjg.v20.i16.474510.3748/wjg.v20.i16.4745400051224782628Search in Google Scholar

26. J. Wang, K. Ma, M. Han, W. Guo, J. Huang, D. Yang, X. Zhao, J. Song, D. Tian and J. Qi, Nucleoside analogs prevent disease progression in HBV-related acute-on-chronic liver failure: validation of the TPPM model, Hepatol. Int. 8 (2014) 64-71; https://doi.org/10.1007/s12072-013-9485-510.1007/s12072-013-9485-526202407Search in Google Scholar

27. J. Wang, J. Liu, C. Qi, T. Yan, F. Cao, L. Jin, Y. He, Y. Yang, S. Zhang, T. Chen and Y. Zhao, Efficacy of tenofovir disoproxil fumarate to prevent vertical transmission in mothers with lamivudineresistant HBV, Antivir. Ther. 20 (2015) 681-687; https://doi.org/10.3851/IMP298110.3851/IMP298126215771Search in Google Scholar

28. B. Ceylan, C. Yardimci, M. Fincanci, G. Eren, U. Tozalgan, C. Muderrisoglu and Y. Akkoyunlu, Comparison of tenofovir and entecavir in patients with chronic HBV infection, Eur. Rev. Med. Pharmacol. Sci. 17 (2013) 2467-2473.Search in Google Scholar

29. Y. B. Lee, E. U. Jung, B. H. Kim, J. H. Lee, H. Cho, H. Ahn, W. M. Choi, Y. Y. Cho, M. Lee and J. J. Yoo, Tenofovir monotherapy versus tenofovir plus lamivudine or telbivudine combination therapy in treatment of lamivudine-resistant chronic hepatitis B, Antimicrob. Agents Ch. 59 (2014) 972-978; https://doi.org/10.1128/AAC.04454-1410.1128/AAC.04454-14433586525421484Search in Google Scholar

30. Z. Krastev, D. Petrova, I. Kotzev, M. K. Celen, M. Mendelson, R. Chandra, P. Pandey and K. Hamed, Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study, World J. Hepatol. 8 (2016) 1402-1413; https://doi.org/10.4254/wjh.v8.i32.140210.4254/wjh.v8.i32.1402511447627917266Search in Google Scholar

31. P. Marcellin, Tenofovir disoproxil fumarate versus adefovir dipivoxil for chronic hepatitis B, New Engl. J. Med. 359 (2009) 2442-2455; https://doi.org/10.1056/NEJMoa080287810.1056/NEJMoa080287819052126Search in Google Scholar

32. V. Ratziu, V. Thibault, Y. Benhamou and T. Poynard, Successful rescue therapy with tenofovir in a patient with hepatic decompensation andesistant HBV mutant, Comp. Hepatol. 5 ( 2006) 1-4; https://doi.org/10.1186/1476-5926-5-110.1186/1476-5926-5-1136372816405720Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo